Radiopharm Theranostics Limited Sponsored ADR
(NASDAQ: RADX)
Radiopharm Theranostics Ltd. operates as a pre-clinical and clinical research company. It focuses on the development of radiopharmaceutical products for diagnostic and therapeutic uses in areas of high unmet medical need. The company is founded by Paul A. Hopper in 2021 headquartered Carlton, Australia.
4.590
+0.105
(+2.34%)
Range
4.376 - 4.590
(4.89%)
Open
4.570
Previous Close
4.485
Bid Price
-
Bid Volume
-
Ask Price
-
Ask Volume
-
Volume
2,707
Value
-
Remark
Delayed prices. Updated at 05 Dec 2025 05:00.
Data powered by
View All Events
Loading Chart...
Please login to view stock data and analysis
